|
|
|
12mths ended
31-Mar-10
$'000
|
12 mths ended
31-Mar-09
$'000
|
15 mths ended
31-Dec-08
$'000
|
12 mths ended
31-Dec-06
$'000
|
12 mths ended
31-Dec-05
$'000
|
Operating Revenue
|
84,934
|
71,440
|
65,182
|
39,295
|
31,319
|
EBITDAF(i)
|
10,976
|
6,088
|
2,484
|
4,762
|
4,092
|
Impairment and
Fair Value
adjustments
|
(223)
|
746
|
2,128-
|
-
|
-
|
Depreciation and
amortisation
|
2,222
|
1,984
|
1,883
|
724
|
950
|
EBIT
|
8,977
|
3,358
|
(1,527)
|
4,038
|
3,142
|
Interest Costs - net
|
1,745 |
2,640 |
2,740 |
1,062 |
547 |
Net Operating Surplus (ii)
|
7,009 |
1,464 |
(2,139) |
2,976 |
2,595 |
Net Profit/(Loss) after tax
|
5,012 |
770 |
(3,701) |
2,113 |
1,590 |
Total assets
|
107,248 |
104,402 |
108,320 |
53,323 |
31,186 |
Total shareholder funds
|
65,916 |
60,416 |
60,699 |
30,626 |
16,911
|
Shareholder equity ratio
|
61.5% |
57.9% |
56.0% |
57.0% |
54.0% |
Earnings per share NPAT
(NZ cents)
|
18.09 |
2.71 |
(17.04) |
15.50 |
12.30 |
Dividend per share
(NZ cents)
|
8.00 |
- |
- |
5.00 |
5.00 |
Dividend % of NPAT
|
43.7% |
- |
- |
36.8% |
40.7% |
Dividend - interim and
final
|
2,191 |
- |
- |
777 |
647 |
NPAT on net assets
|
7.6% |
1.3% |
(6.1%) |
6.9% |
9.4% |
EBITDAF on operating
revenue
|
12.9% |
8.5% |
3.8% |
12.1% |
13.1% |
| Export Revenue |
67,708 |
57,616 |
47,527, |
25,954 |
18,757 |
| % of operating revenue |
79.7% |
80.6% |
72.9% |
66.0% |
59.9% |
| Return on Sales - ROS (iv) |
10.6% |
4.7% |
(2.3%) |
10.3% |
10.0% |
| Return on Capital Employed - ROCE(v) |
11.6% |
3.7% |
(1.7%) |
9.3% |
12.0% |
(i) EBITDAF - Ernings before interest, tax, depreciation, amortisation, impairments and fair value movements of financial instruments. (ii) Net Operating Surplus - Earning after interest, depreciation and amortisation but before tax, impairments and fair value movements of financial instruments. (iii) A fully imputed two cent dividend was paid during the year ended 31st March 2010. A further six cnets fully imputed dividend will be paid on the 25th June2010. This equates to a distribution of earnings of 43.7% (iv) ROS + EBIT/ Total Operating Revenue (v) ROCE = EBIT/ (Total shareholder Funds + Net Debt)
|
|